← Eichor
Condition: Haematopoietic Stem Cell Transplantation Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Haematopoietic Stem Cell Transplantation

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Haplo-Cord HSCT for AML/MDS
NA · 4 location(s) · Fujian Medical University Union Hospital · NCT07588360Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease
Phase 1/Phase 2 · 4 location(s) · Arkansas Children's Hospital Research Institute · NCT07252050Blinatumomab for Relapsed Acute B Lymphoblastic Leukemia After Transplantation
Phase 4 · 1 location(s) · Suping ZHANG · NCT06339775Massage Impact on Sleep in Pediatric Oncology
NA · 2 location(s) · Children's Hospital of Philadelphia · NCT06892158A Study Evaluating the Safety and Efficacy of LentiRed Drug Product in Transfusion-dependent β-Thalassemia [TDT]
EARLY_Phase 1 · 1 location(s) · First Affiliated Hospital of Guangxi Medical University · NCT05762510Analysis of the Immunobiology of Acute Myeloid Leukemia Relapses After Allogeneic Hematopoietic Stem Cell Transplant (HS
Phase N/A · 1 location(s) · Ciceri Fabio · NCT05124288A Single-arm, Prospective Study of a Clad-LABU Conditioning Regimen in HSCT for R/R MDS/AML in Elderly Patients
NA · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT07500753Optimizing GVHD Prophylaxis After Allogeneic Hematopoietic Cell Transplantation
Phase 2 · 1 location(s) · University of Nebraska · NCT06799195Identification of Plasma Biomarkers for Early Diagnosis of Transplant-associated Thrombotic Microangiopathy
Phase N/A · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06102694BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
Phase 2 · 6 location(s) · Dana-Farber Cancer Institute · NCT05922761Precision Medicine for Stem Cell Transplantation
Phase N/A · 3 location(s) · University of Manchester · NCT05567289Platelet Transfusions in Hematopoietic Stem Cell Transplantation (The PATH III Trial)
Phase 3 · 12 location(s) · Ottawa Hospital Research Institute · NCT04448184Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological M
Phase 2 · 1 location(s) · Fred Hutchinson Cancer Center · NCT04195633Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide in Patients With
Phase 2 · 35 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05126849Efficacy of High-Level Laser Therapy in Managing Oral Mucositis Among Pediatric Patients Undergoing Hematopoietic Stem C
NA · 1 location(s) · Ain Shams University · NCT07436650Safety and Efficacy of Iguratimod in the Treatment of Chronic GVHD
Phase 3 · 1 location(s) · Xuzhou Medical University · NCT06244628Treatment of CD19 Chimeric Antigen Receptor T Cells for Pediatric Patients With CD19-positive B-cell Acute Lymphoblastic
Phase 2 · 1 location(s) · Seoul National University Hospital · NCT06247501Treosulfan Therapeutic Drug Monitoring in Pediatric Hematopoietic Stem Cell Transplant Recipients
Phase N/A · 10 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT06861257Study on the Efficacy and Safety of the TmBU Conditioning Regimen in High-risk or Relapsed/Refractory Acute Leukemia
Phase 2 · 1 location(s) · The First Affiliated Hospital of Soochow University · NCT06816134Safety, Tolerability, and Pharmacokinetics of Donor-derived CD19 CAR Therapy Bridged Allo-HSCT and Sequential Donor-deri
Phase 1 · 1 location(s) · Beijing GoBroad Hospital · NCT06326008A Cohort Study on the Association Between the ANS Function and Acute GvHD
Phase N/A · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT07374874Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
Phase 2 · 3 location(s) · Children's Hospital of Philadelphia · NCT05194397Evaluation of Recombinant Humanized Anti-CD25 Monoclonal Antibody for Preventing Graft-versus-host Disease After Haploid
Phase 2 · 5 location(s) · Rongrong Liu · NCT06657391Efficacy Safety Study of Gene Therapy for Sickle Cell DiseaseSCD Using Autologous CD34+ Cells Transduced ex Vivo, Carryi
Phase 1/Phase 2 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07432867Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hem
Phase 2 · 1 location(s) · Fred Hutchinson Cancer Center · NCT06013423Post-Transplant Cyclophosphamide, Bortezomib and Abatacept for the Prevention of Graft-versus-Host-Disease (GvHD)
Phase 1/Phase 2 · 1 location(s) · Northwell Health · NCT05289167Haploidentical Transplantation With Pre-Transplant Immunosuppressive Therapy for Patients With Sickle Cell Disease
Phase 1 · 1 location(s) · City of Hope Medical Center · NCT03279094Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister Donor
Phase 1/Phase 2 · 1 location(s) · Jeffrey Veale, MD · NCT03707262CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT
Phase 3 · 1 location(s) · Peking University People's Hospital · NCT07441291Orelabrutinib Combined With Standard Immunochemotherapy With or Without Autologous Hematopoietic Stem Cell Transplantati
Phase 2 · 1 location(s) · The Affiliated Hospital of Xuzhou Medical University · NCT07680933
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.